Startup Showcase: NovaVive Inc. – Transforming Animal Health with Immunobiology-Based Technologies

NovaVive Inc. is a privately owned animal health immunobiology company that is changing the game in the field of veterinary medicine. Based in Belleville, Ontario, the company was founded in 2014 by Graeme McRae, the Founder and Chairman Emeritus of Bioniche Life Sciences Inc. NovaVive is dedicated to introducing immunobiology-based technologies that are scientifically sound and address unmet veterinary medical needs.

NovaVive’s Technologies: A Revolutionary Approach to Animal Health

The company’s flagship technology is the Mycobacterium Cell Wall Fraction (MCWF) platform, which NovaVive acquired in 2014 from Bioniche Animal Health. This innovative platform was originally developed as an alternative to antibiotics for animals and has proven to be highly effective in treating various diseases in animals.

MCWF-based immunotherapies are also used to treat cancer in animals and have been modified to treat bladder cancer in humans. NovaVive acquired the global license to MCNA for treating animal cancers, which is an advanced formulation of mycobacterium cell walls and nucleic acids formulated for human applications.

With these innovative technologies, NovaVive is paving the way for a new era in animal health. The company’s approach is grounded in the belief that a healthy immune system is key to maintaining overall health and preventing disease. By harnessing the power of immunobiology, NovaVive is able to develop treatments that are effective, safe, and affordable.

The Leadership Team: Experience and Success

NovaVive is managed by a group of experienced executives who collectively have successfully developed veterinary technologies that have taken large global market share in the face of rigorous competition. With a track record of success in the field of animal health, the leadership team at NovaVive is well-equipped to drive the company’s growth and success.

The Future of Animal Health: NovaVive’s Vision

NovaVive’s vision is to transform the field of animal health by introducing innovative and effective immunobiology-based technologies. The company is committed to addressing unmet veterinary medical needs and improving the health and well-being of animals worldwide.


As NovaVive continues to innovate and expand its offerings, it is poised to become a leader in the animal health industry. With its cutting-edge technologies, experienced leadership team, and commitment to excellence, NovaVive is a company to watch in the coming years.




Looking to amplify your brand’s impact in Canada’s thriving startup and investment sector? Join the league of innovators, leaders, and decision-makers making a difference through Canada Venture News. Engage with our audience of startup founders, investors, and executives through sponsored articles and partnerships. Discover more on our Promotion & Sponsored Articles page or email us directly at [email protected]. Let’s shape your story together.

Canada Venture News is a Canadian venture magazine that covers startups, business, technology, and innovation in Canada. The online publication provides news, insights, and resources for entrepreneurs, investors, and business professionals, featuring articles, interviews, and analysis of the latest trends and developments in the Canadian startup ecosystem.